189 lines
8.7 KiB
JSON
189 lines
8.7 KiB
JSON
{
|
||
"dataType": "CVE_RECORD",
|
||
"dataVersion": "5.1",
|
||
"cveMetadata": {
|
||
"cveId": "CVE-2025-2230",
|
||
"assignerOrgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
|
||
"state": "PUBLISHED",
|
||
"assignerShortName": "icscert",
|
||
"dateReserved": "2025-03-11T20:14:50.017Z",
|
||
"datePublished": "2025-03-13T18:14:43.573Z",
|
||
"dateUpdated": "2025-03-17T20:05:56.939Z"
|
||
},
|
||
"containers": {
|
||
"cna": {
|
||
"affected": [
|
||
{
|
||
"defaultStatus": "unaffected",
|
||
"product": "Intellispace Cardiovascular (ISCV)",
|
||
"vendor": "Philips",
|
||
"versions": [
|
||
{
|
||
"lessThanOrEqual": "5.1",
|
||
"status": "affected",
|
||
"version": "0",
|
||
"versionType": "custom"
|
||
}
|
||
]
|
||
}
|
||
],
|
||
"credits": [
|
||
{
|
||
"lang": "en",
|
||
"type": "finder",
|
||
"value": "Joe Dillon reported these vulnerabilities to Philips."
|
||
}
|
||
],
|
||
"descriptions": [
|
||
{
|
||
"lang": "en",
|
||
"supportingMedia": [
|
||
{
|
||
"base64": false,
|
||
"type": "text/html",
|
||
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
|
||
}
|
||
],
|
||
"value": "A flaw exists in the Windows login flow where an AuthContext token can \nbe exploited for replay attacks and authentication bypass."
|
||
}
|
||
],
|
||
"metrics": [
|
||
{
|
||
"cvssV3_1": {
|
||
"attackComplexity": "LOW",
|
||
"attackVector": "LOCAL",
|
||
"availabilityImpact": "NONE",
|
||
"baseScore": 7.7,
|
||
"baseSeverity": "HIGH",
|
||
"confidentialityImpact": "HIGH",
|
||
"integrityImpact": "HIGH",
|
||
"privilegesRequired": "NONE",
|
||
"scope": "UNCHANGED",
|
||
"userInteraction": "NONE",
|
||
"vectorString": "CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N",
|
||
"version": "3.1"
|
||
},
|
||
"format": "CVSS",
|
||
"scenarios": [
|
||
{
|
||
"lang": "en",
|
||
"value": "GENERAL"
|
||
}
|
||
]
|
||
},
|
||
{
|
||
"cvssV4_0": {
|
||
"Automatable": "NOT_DEFINED",
|
||
"Recovery": "NOT_DEFINED",
|
||
"Safety": "NOT_DEFINED",
|
||
"attackComplexity": "LOW",
|
||
"attackRequirements": "NONE",
|
||
"attackVector": "LOCAL",
|
||
"baseScore": 8.5,
|
||
"baseSeverity": "HIGH",
|
||
"privilegesRequired": "NONE",
|
||
"providerUrgency": "NOT_DEFINED",
|
||
"subAvailabilityImpact": "NONE",
|
||
"subConfidentialityImpact": "NONE",
|
||
"subIntegrityImpact": "NONE",
|
||
"userInteraction": "NONE",
|
||
"valueDensity": "NOT_DEFINED",
|
||
"vectorString": "CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N",
|
||
"version": "4.0",
|
||
"vulnAvailabilityImpact": "NONE",
|
||
"vulnConfidentialityImpact": "HIGH",
|
||
"vulnIntegrityImpact": "HIGH",
|
||
"vulnerabilityResponseEffort": "NOT_DEFINED"
|
||
},
|
||
"format": "CVSS",
|
||
"scenarios": [
|
||
{
|
||
"lang": "en",
|
||
"value": "GENERAL"
|
||
}
|
||
]
|
||
}
|
||
],
|
||
"problemTypes": [
|
||
{
|
||
"descriptions": [
|
||
{
|
||
"cweId": "CWE-287",
|
||
"description": "CWE-287 Improper Authentication",
|
||
"lang": "en",
|
||
"type": "CWE"
|
||
}
|
||
]
|
||
}
|
||
],
|
||
"providerMetadata": {
|
||
"orgId": "7d14cffa-0d7d-4270-9dc0-52cabd5a23a6",
|
||
"shortName": "icscert",
|
||
"dateUpdated": "2025-03-17T20:05:56.939Z"
|
||
},
|
||
"references": [
|
||
{
|
||
"url": "https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-072-01"
|
||
},
|
||
{
|
||
"url": "https://www.philips.com/a-w/security/security-advisories.html"
|
||
}
|
||
],
|
||
"solutions": [
|
||
{
|
||
"lang": "en",
|
||
"supportingMedia": [
|
||
{
|
||
"base64": false,
|
||
"type": "text/html",
|
||
"value": "<p>Philips recommends the following mitigations:</p>\n<ul>\n<li>\n\n<span style=\"background-color: rgb(255, 255, 255);\">Resolved in ISCV 5.2, which was released in September 2020.</span>\n\n</li>\n\n<li>Philips recommends users upgrade ISCV installed base to the latest \nISCV version (at the time of this publication is 830089 – IntelliSpace \nCardiovacular 8.0.0.0)</li>\n<li>Please contact a local Philips sales (service) representative to learn how to engage this upgrade process.</li>\n<li>For managed services users, new releases will be made available upon\n resource availability. Releases are subject to country-specific \nregulations.</li>\n</ul>\n<p>Refer to the <a target=\"_blank\" rel=\"nofollow\" href=\"https://www.philips.com/a-w/security/security-advisories.html\">Philips advisory</a>for more details.\n\n<br></p>"
|
||
}
|
||
],
|
||
"value": "Philips recommends the following mitigations:\n\n\n\n * \n\nResolved in ISCV 5.2, which was released in September 2020.\n\n\n\n\n * Philips recommends users upgrade ISCV installed base to the latest \nISCV version (at the time of this publication is 830089 – IntelliSpace \nCardiovacular 8.0.0.0)\n\n * Please contact a local Philips sales (service) representative to learn how to engage this upgrade process.\n\n * For managed services users, new releases will be made available upon\n resource availability. Releases are subject to country-specific \nregulations.\n\n\n\n\nRefer to the Philips advisory https://www.philips.com/a-w/security/security-advisories.html for more details."
|
||
}
|
||
],
|
||
"source": {
|
||
"advisory": "ICSMA-25-072-01",
|
||
"discovery": "EXTERNAL"
|
||
},
|
||
"title": "Philips Intellispace Cardiovascular (ISCV) Improper Authentication",
|
||
"x_generator": {
|
||
"engine": "Vulnogram 0.2.0"
|
||
}
|
||
},
|
||
"adp": [
|
||
{
|
||
"metrics": [
|
||
{
|
||
"other": {
|
||
"type": "ssvc",
|
||
"content": {
|
||
"timestamp": "2025-03-13T19:33:45.514056Z",
|
||
"id": "CVE-2025-2230",
|
||
"options": [
|
||
{
|
||
"Exploitation": "none"
|
||
},
|
||
{
|
||
"Automatable": "no"
|
||
},
|
||
{
|
||
"Technical Impact": "total"
|
||
}
|
||
],
|
||
"role": "CISA Coordinator",
|
||
"version": "2.0.3"
|
||
}
|
||
}
|
||
}
|
||
],
|
||
"title": "CISA ADP Vulnrichment",
|
||
"providerMetadata": {
|
||
"orgId": "134c704f-9b21-4f2e-91b3-4a467353bcc0",
|
||
"shortName": "CISA-ADP",
|
||
"dateUpdated": "2025-03-13T19:34:02.967Z"
|
||
}
|
||
}
|
||
]
|
||
}
|
||
} |